• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Gentherm Announces Dr. Ken Washington as New Independent Director

    10/2/23 8:00:00 AM ET
    $AMZN
    $F
    $MCK
    $MDT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Auto Manufacturing
    Industrials
    Get the next $AMZN alert in real time by email

    NORTHVILLE, Mich., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Dr. Ken Washington has been appointed to the Company's Board of Directors, effective October 2, 2023.

    Dr. Washington is the Senior Vice President, Chief Technology and Innovation Officer of Medtronic plc (NYSE:MDT), a global healthcare technology company that provides device-based medical therapies and services. He was appointed to this position in June 2023, and he leads innovation and the expansion of technology platforms across Medtronic's portfolio. Prior to joining Medtronic, Dr. Washington served as the Vice President of Software Engineering, Consumer Robotics for Amazon Lab126, a premier innovation hub and subsidiary of Amazon.com, Inc. (NASDAQ:AMZN). At Amazon Lab 126, Dr. Washington was responsible for all aspects of the profitability of Amazon's consumer robotics business unit. Before Amazon Lab 126, he held varying positions at Ford Motor Company (NYSE:F), including serving as Chief Technology Officer. At Ford, he led the worldwide research organization, oversaw the development and implementation of Ford's technology strategy and plans, oversaw the autonomous vehicle program, and played a key role in Ford's expansion into emerging mobility opportunities. Dr. Washington worked at Lockheed Martin Corporation as Vice President of the Advanced Technology Center and its first Chief Privacy Officer. Dr. Washington also served for approximately 21 years in various roles at Sandia National Laboratories, including as Chief Information Officer.

    Dr. Washington previously served as a member of the Board of Directors of McKesson Corporation (NYSE:MCK) from July 2019 to October 2021, including as a member of the Compliance and Finance Committees, as well as numerous private company boards and advisory boards of academic institutions.

    "We are pleased to welcome Ken to Gentherm's Board of Directors," said Ronald Hundzinski, Chair of the Board of Gentherm. "Ken brings years of experience in technology, research, and strategy across global automotive and medical organizations that will be a valuable asset to Gentherm's Board."

    "Ken's strong track record of leading technology development and execution makes him an ideal Board member to help drive innovation and strategy to strengthen shareholder value," said Phil Eyler, President and CEO of Gentherm. "I look forward to his insight and counsel and am excited for him to join as a new member of our Board of Directors."

    Dr. Washington earned his bachelor's, master's, and doctorate degrees in nuclear engineering from Texas A&M University.

    Investor Contact

    Yijing Brentano

    [email protected]

    248.308.1702

    Media Contact

    Melissa Fischer

    [email protected]

    248.289.9702

    About Gentherm

    Gentherm (NASDAQ:THRM) is the global market leader in innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests, and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Malta, Mexico, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.



    Primary Logo

    Get the next $AMZN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMZN
    $F
    $MCK
    $MDT

    CompanyDatePrice TargetRatingAnalyst
    Medtronic plc.
    $MDT
    11/19/2025$111.00Sell → Neutral
    Goldman
    Amazon.com Inc.
    $AMZN
    11/18/2025$250.00Buy → Neutral
    Rothschild & Co Redburn
    Amazon.com Inc.
    $AMZN
    11/4/2025$300.00 → $315.00Outperform
    Mizuho
    Amazon.com Inc.
    $AMZN
    10/31/2025$275.00 → $300.00Overweight
    Barclays
    Amazon.com Inc.
    $AMZN
    10/31/2025$285.00 → $300.00Mkt Outperform
    Citizens JMP
    Amazon.com Inc.
    $AMZN
    10/31/2025$280.00 → $300.00Buy
    Canaccord Genuity
    Amazon.com Inc.
    $AMZN
    10/31/2025$280.00 → $292.00Overweight
    Wells Fargo
    Amazon.com Inc.
    $AMZN
    10/31/2025$270.00 → $320.00Buy
    Citigroup
    More analyst ratings

    $AMZN
    $F
    $MCK
    $MDT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Medtronic upgraded by Goldman with a new price target

    Goldman upgraded Medtronic from Sell to Neutral and set a new price target of $111.00

    11/19/25 8:47:22 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amazon downgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn downgraded Amazon from Buy to Neutral and set a new price target of $250.00

    11/18/25 8:17:10 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Mizuho reiterated coverage on Amazon with a new price target

    Mizuho reiterated coverage of Amazon with a rating of Outperform and set a new price target of $315.00 from $300.00 previously

    11/4/25 10:48:43 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP Global Ops & Supply Chain Smith Gregory L sold $3,058,451 worth of Ordinary Shares (30,000 units at $101.95), decreasing direct ownership by 39% to 46,016 units (SEC Form 4)

    4 - Medtronic plc (0001613103) (Issuer)

    11/21/25 4:13:06 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    CEO Worldwide Amazon Stores Herrington Douglas J converted options into 11,959 shares and sold $1,113,263 worth of shares (4,784 units at $232.71), increasing direct ownership by 1% to 498,182 units (SEC Form 4)

    4 - AMAZON COM INC (0001018724) (Issuer)

    11/18/25 6:52:23 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Stonesifer Patricia Q converted options into 2,473 shares, increasing direct ownership by 5% to 53,639 units (SEC Form 4)

    4 - AMAZON COM INC (0001018724) (Issuer)

    11/18/25 6:42:40 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AWS and HUMAIN Expand Partnership with NVIDIA AI Infrastructure and AWS AI Chip Deal to Drive Global AI Innovation

    Expanded partnership includes deployment of up to 150,000 AI accelerators including the latest NVIDIA GB300s AI infrastructure and AWS's Trainium chips. Amazon Bedrock will provide customers access to best-in-class foundation models optimized across diverse, high performance AI chip infrastructures. AWS becomes HUMAIN's preferred AI partner with AWS and HUMAIN collaborating to bring AI compute and services to customers worldwide. Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ:AMZN), and HUMAIN, a Public Investment Fund (PIF) company delivering global full-stack AI solutions, announced today at the U.S.-Saudi Investment Forum their plans to provide, deploy and

    11/19/25 1:38:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum

    Cardiac Ablation Solutions growth of 71% on strength of pulsed field ablation (PFA) portfolio; Raising FY26 revenue and EPS guidance GALWAY, Ireland, Nov. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced financial results for its second quarter (Q2) of fiscal year 2026 (FY26), which ended October 24, 2025. Q2 Key Highlights Revenue of $9.0 billion, increased 6.6% as reported and 5.5% organic, 75 basis points above guidance midpointGAAP diluted EPS of $1.07 increased 8%; non-GAAP diluted EPS of $1.36 increased 8%, above guidanceRaising FY26 guidance: 5.5% organic revenue growth, $5.62-$5.66 adjusted

    11/18/25 6:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Box and AWS Launch Multi-Year AI Collaboration to Transform Enterprise Content Management

    Box and AWS signed a multi-year strategic collaboration agreement to transform agentic AI capabilities for the future of enterprise content New Box integrations with AWS include support for Amazon Quick Suite, Amazon Q Developer, Amazon Bedrock AgentCore, Kiro, and Amazon Strands Box will be available in AWS Marketplace to streamline procurement and accelerate the value of both platforms Box, Inc. (NYSE:BOX), the leading Intelligent Content Management (ICM) platform, and Amazon Web Services, Inc, (AWS), an Amazon.com, Inc. company (NASDAQ:AMZN), today announced a new multi-year strategic collaboration agreement (SCA) to transform how organizations securely use AI to extract value from

    11/17/25 11:00:00 AM ET
    $AMZN
    $BOX
    Catalog/Specialty Distribution
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology

    $AMZN
    $F
    $MCK
    $MDT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    $AMZN
    $F
    $MCK
    $MDT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $AMZN
    $F
    $MCK
    $MDT
    SEC Filings

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    November 14, 2023 - FDA Roundup: November 14, 2023

    For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

    11/14/23 3:26:18 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Thornton John L bought $99,189 worth of shares (7,520 units at $13.19), increasing direct ownership by 2% to 448,697 units (SEC Form 4)

    4 - FORD MOTOR CO (0000037996) (Issuer)

    11/18/25 4:31:54 PM ET
    $F
    Auto Manufacturing
    Industrials

    Director Jellison William R bought $462,750 worth of Ordinary Shares (5,000 units at $92.55) (SEC Form 4)

    4 - Medtronic plc (0001613103) (Issuer)

    8/25/25 5:18:06 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Washington Kenneth E bought $47,702 worth of shares (1,700 units at $28.06), increasing direct ownership by 18% to 10,965 units (SEC Form 4)

    4 - Gentherm Inc (0000903129) (Issuer)

    5/13/25 4:10:38 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    Ford Motor Company filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FORD MOTOR CO (0000037996) (Filer)

    11/21/25 1:32:27 PM ET
    $F
    Auto Manufacturing
    Industrials

    Amazon.com Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - AMAZON COM INC (0001018724) (Filer)

    11/20/25 5:00:42 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 424B5 filed by Amazon.com Inc.

    424B5 - AMAZON COM INC (0001018724) (Filer)

    11/19/25 4:10:47 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Leadership Updates

    Live Leadership Updates

    View All

    Ford to Boost F-150, Super Duty Production, Add Up to 1,000 Jobs in Mich., Ky. to Meet Demand, Recover from Novelis Fire

    Ford plans to increase F-150 and F-Series Super Duty production by more than 50,000 trucks in 2026 to meet demand and recover production losses due to the Novelis plant fire The company plans to add a third crew at its Dearborn Truck Plant at the Ford Rouge Complex in Michigan for F-150 production and additional employees at Kentucky Truck Plant in Louisville for F-Series Super Duty assembly Ford will add up to 900 new jobs at the Ford Rouge Complex and 100 new positions at Kentucky Truck Plant Ford today announced plans to significantly increase F-150 and F-Series Super Duty truck production to meet strong customer demand and recover production losses stemming from the fire at su

    10/23/25 4:01:00 PM ET
    $F
    Auto Manufacturing
    Industrials

    ChargeScape and PSEG Long Island Partner to Enroll BMW and Ford Electric Vehicles in First-Ever Grid Reliability Program Participation

    HICKSVILLE, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- ChargeScape, a joint venture between BMW, Honda, Ford, and Nissan, today announced a partnership with PSEG Long Island to enroll electric vehicles (EVs) in the utility's Peak Load Reduction program, a first in the nine-year history of the utility's peak load reduction programs. Designed to alleviate strain on the power grid during summer months, the initiative will leverage ChargeScape's AI-powered technology platform and aims to intelligently integrate more than 4,000 BMW EV drivers and 2,200 Ford EV drivers into the power grid. Participating customers will receive financial incentives for helping to support grid stability and community

    7/22/25 7:00:00 AM ET
    $F
    Auto Manufacturing
    Industrials

    Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company

    GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent.  Chad brings over 25 years of financial leadership experience across healthcare, consumer, and industrial sectors. Most recently, he served as CFO at BIC (BB:PA), a pu

    7/8/25 8:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

    SC 13G/A - AMAZON COM INC (0001018724) (Subject)

    11/8/24 4:33:15 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

    SC 13G/A - AMAZON COM INC (0001018724) (Filed by)

    11/7/24 5:23:12 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SC 13G/A filed by Medtronic plc. (Amendment)

    SC 13G/A - Medtronic plc (0001613103) (Subject)

    2/13/24 5:09:43 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Financials

    Live finance-specific insights

    View All

    Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum

    Cardiac Ablation Solutions growth of 71% on strength of pulsed field ablation (PFA) portfolio; Raising FY26 revenue and EPS guidance GALWAY, Ireland, Nov. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced financial results for its second quarter (Q2) of fiscal year 2026 (FY26), which ended October 24, 2025. Q2 Key Highlights Revenue of $9.0 billion, increased 6.6% as reported and 5.5% organic, 75 basis points above guidance midpointGAAP diluted EPS of $1.07 increased 8%; non-GAAP diluted EPS of $1.36 increased 8%, above guidanceRaising FY26 guidance: 5.5% organic revenue growth, $5.62-$5.66 adjusted

    11/18/25 6:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Orchestra BioMed to Host Business Update Call on November 12, 2025

    NEW HOPE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) ("Orchestra BioMed" or the "Company"), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, today announced that company management will host a business update call on Wednesday, November 12th at 8:00 AM ET. The business update will focus on recent significant clinical, strategic and financing developments, including the Company's additional strategic investment from and collaboration expansion with Medtronic, its new strategic capital relationship with Ligand, its new right of first refusal agr

    11/3/25 8:00:00 AM ET
    $MDT
    $OBIO
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Medicinal Chemicals and Botanical Products

    Amazon.com Announces Third Quarter Results

    Amazon.com, Inc. (NASDAQ:AMZN) today announced financial results for its third quarter ended September 30, 2025. Net sales increased 13% to $180.2 billion in the third quarter, compared with $158.9 billion in third quarter 2024. Excluding the $1.5 billion favorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 12% compared with third quarter 2024. North America segment sales increased 11% year-over-year to $106.3 billion. International segment sales increased 14% year-over-year to $40.9 billion, or increased 10% excluding changes in foreign exchange rates. AWS segment sales increased 20% year-over-year to $33.0 billion.

    10/30/25 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary